Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Sarepta Therapeutics Q2 2024 Adj. EPS $0.44 Beats $0.01 Estimate, Sales $362.931M Miss $391.406M Estimate

Author: Benzinga Newsdesk | August 07, 2024 04:09pm
Sarepta Therapeutics (NASDAQ:SRPT) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.01 by 4300 percent. The company reported quarterly sales of $362.931 million which missed the analyst consensus estimate of $391.406 million by 7.28 percent. This is a 38.93 percent increase over sales of $261.238 million the same period last year.

Posted In: SRPT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist